Thanks. Not sure you can answer these two questio
Post# of 145746
1. Do we know that Dr.BP started measuring viral load with the first patient in both trials? I know that the pre-print of his manuscript contained Plasma Viral Load graphs. Just not sure every trial subject was tested and documented that way.
2. Is the FDA possibly so stringent in their submission regulations that there is facility for providing additional data points beyond what is officially included in the trial protocol?
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)